Kolon TissueGene financial statements
KRX:950160 · KOSDAQ · Healthcare · sector #23₩14,300-2.05%Oct 29 close
Kolon TissueGene's 2025 annual results accompany close-price data dated 2026-10-29. 2025 revenue was KRW 3.63M. 2025 operating profit was −KRW 15.7M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy